You'll experience a return of hunger and cravings, stalling or even reversing your progress
GLP-1 (glucagon-like peptide-1) is a natural hormone your body produces after eating
CHICAGO Patients with diabetes who used GLP-1 receptor agonists demonstrated lower risks for certain rheumatic diseases, including rheumatoid arthritis and gout, according to data presented at ACR Convergence 2025
Biologics face slower erosion because interchangeability standards, formulary dynamics, and physician reluctance create friction that delays adoption
Ma RC, Del Prato S, Gallwitz B, Shivane VK, Lewis-DAgostino D, Bailes Z, Patel S, Lee J, von Eynatten M, Di Domenico M, et al
Not everyone will need full-dose GLP-1 therapy, but microdosing could provide enough benefit to improve metabolic health, reduce inflammation, or modulate immune function